News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood


3/27/2012 9:59:56 AM

IRVINE, Calif., March 26, 2012 /PRNewswire/ -- Aviir, a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests and Guard A Heart, a non-profit foundation committed to raising awareness about heart disease prevention, will sponsor Storyland, a Red Carpet Charity Extravaganza in Hollywood on March 16th.

The party will have a whimsical Dr. Seuss theme, as homage to the children the charity gala benefits. A portion of the proceeds will go to the L.A. based non-profit "Reading, Writing, its Exciting," a program which helps at-risk children learn to read and write.

"It is our privilege to work in collaboration with Caus;ology to help further childhood literacy for those most vulnerable," said Dr. Harrington, CEO of Aviir Diagnostic Laboratories. "Through our support of this event we hope to raise awareness on the importance of heart disease prevention. As many as one in three kids and teens are overweight, contributing to early onset heart disease. Education is key for this highly controllable disease, and reading and writing is the foundation of any education. We are excited to be fostering literacy for children through this fun event."

The gala will be held at the world famous RISE building at Hollywood and Highland and will include a celebrity host, open bar, gourmet catering, DJ EQ, aerial dancers, photo booths, decadent desserts and event gift bags.

Tickets for this event can be purchased at: http://www.storyland.mobi/Storyland/After_Party_Tickets.html

About Aviir

Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the development of a cardiac event. Aviir's proprietary MIRisk and TruRisk assessments objectively identify, by a simple blood draw, individuals who are at a high risk of a cardiac event over the next five years. Aviir's CLIA laboratory (Irvine, CA) complements these novel tests with a wide range of additional tests for risk assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders including pharmacogenomic and genetic tests. The company has adopted a unique clinical laboratory service model to provide physicians better diagnostic tools that improve cardiovascular health of their patients. The company is privately owned and funded by leading life science venture capital firms. Please visit www.aviir.com for more information.

About Guard A Heart

Guard A Heart is a non-profit foundation dedicated to raising awareness of heart disease prevention by spreading the word to guard your heart and save your life. Cardiovascular disease is the leading cause of death in the United States. If individuals know their risk and take the necessary steps, the good news is that most cardiovascular disease is preventable. Although heart disease is typically diagnosed in adulthood, its roots are often found in childhood. Compelling research has shown that plaque buildup in the arterial walls begins very early in life and progresses through increasing degrees of atherosclerosis. Intervention strategies and healthy lifestyle changes to reduce heart disease risk should begin in childhood when reversal of the process is easier, not later in life when the disease is more fully developed. Guard a Heart Foundation provides funding for individuals who are unable to pay for cardiac risk assessments. Please visit www.guardaheart.org for more information.

For media inquiries, please contact:
Dina Scaglione
(949)910-9401
dina.scaglione@aviir.com

SOURCE Aviir


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES